Learn More
Our previous studies have demonstrated that doses of 300–50 mg/kg 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) injected subcutaneously into pregnant hamsters cause a 44% incidence of(More)
  • 1